Rheumatic Disease Clinics of North America. Drug safety: managing innovation in rheumatology. Foreword.
作者信息
Weisman Michael H
机构信息
Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA 90024, USA.
出版信息
Rheum Dis Clin North Am. 2012 Nov;38(4):ix-x. doi: 10.1016/j.rdc.2012.09.004. Epub 2012 Oct 5.
PMID:23137584
Abstract
摘要
相似文献
1
Rheumatic Disease Clinics of North America. Drug safety: managing innovation in rheumatology. Foreword.
Rheum Dis Clin North Am. 2012 Nov;38(4):ix-x. doi: 10.1016/j.rdc.2012.09.004. Epub 2012 Oct 5.
2
Refining drug safety in rheumatology.
Rheum Dis Clin North Am. 2012 Nov;38(4):xi-xiv. doi: 10.1016/j.rdc.2012.10.001.
3
[Biosimilars].
Z Rheumatol. 2015 Oct;74(8):670-1. doi: 10.1007/s00393-014-1490-0.
4
Recent advances in Pediatric Rheumatology: July 2015-June 2016.
Int J Rheum Dis. 2017 Apr;20(4):504-509. doi: 10.1111/1756-185X.13043. Epub 2017 Feb 16.
5
TPMT testing in rheumatology: any better than routine monitoring?
Rheumatology (Oxford). 2007 May;46(5):727-9. doi: 10.1093/rheumatology/kel427. Epub 2007 Jan 25.
6
[New trends in rheumatology. The Danish Society of Rheumatology].
Ugeskr Laeger. 2003 Mar 17;165(12):1255.
7
[Current status of methotrexate].
Z Rheumatol. 2011 Feb;70(2):99-100. doi: 10.1007/s00393-010-0711-4.
8
Neutropenia in the Elderly: A Rheumatology Perspective.
Drugs Aging. 2016 Aug;33(8):585-601. doi: 10.1007/s40266-016-0383-0.
9
[Continuous quick development of rheumatology].
Ugeskr Laeger. 2009 Mar 23;171(13):1092.
10
Advances in targeted therapies XII. Preface.
Ann Rheum Dis. 2011 Mar;70 Suppl 1:i1. doi: 10.1136/ard.2010.141044.
Zotero 插件